Adjunct professor and Research group leader, Dr. Moshe Finel has joined SBW Scientific Advisory Board.
Dr Finel is a Group leader at the Centre for Drug Research (CDR), Faculty of Pharmacy, University of Helsinki, Finland. Dr. Finel got his M.Sc. in Life Sciences in 1983 from the Weizmann Institute of Science, Rehovot, Israel and his Ph.D. in Biochemistry in 1989 from the University of Helsinki. He obtained postdoctoral training in the Laboratory of Molecular Biology, Medical Research Council, Cambridge, UK.
Dr. Finel’s research interests are in Phase II / conjugation drug metabolism, mainly the glucuronidation of drugs and related compounds, as well as the enzymes that catalyze these reactions, the UDP-glucuronosyltransferases (UGTs). Dr. Finel has published over 100 publications and he has supervised many Ph.D. theses.